MARAVAI LIFESCIENCES HOLDINGS, INC. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Maravai Lifesciences Holdings, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2020 to Q3 2024.
  • Maravai Lifesciences Holdings, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$99M, a 1433% decline year-over-year.
  • Maravai Lifesciences Holdings, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$225M, a 1015% decline year-over-year.
  • Maravai Lifesciences Holdings, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$119M, a 154% decline from 2022.
  • Maravai Lifesciences Holdings, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was $220M, a 21% increase from 2021.
  • Maravai Lifesciences Holdings, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was $182M, a 105% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$225M -$99M -$92.6M -1433% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 -$132M -$7.59M -$1.04M -16% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 -$131M -$12.1M -$12M Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 -$119M -$106M -$144M -382% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 $24.6M -$6.46M -$50.9M -115% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 $75.5M -$6.54M -$77.8M -109% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $153M -$67K* -$66.9M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $220M $37.6M -$18.2M -32.6% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 $238M $44.5M -$9.49M -17.6% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 $248M $71.2M +$22.1M +45% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $226M $66.9M +$43.8M +189% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $182M $55.8M +$30.6M +121% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-29
Q3 2021 $151M $54M +$15M +38.5% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-04
Q2 2021 $136M $49.1M +$47.7M +3353% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-05
Q1 2021 $88.7M $23.1M -$287K -1.23% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q4 2020 $89M $25.2M Oct 1, 2020 Dec 31, 2020 10-K 2023-02-28
Q3 2020 $39M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $1.42M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-11
Q1 2020 $23.4M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.